Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


US, Iran at odds on nuclear inspections, frozen assets in deal to end war
Oman establishes temporary shipping corridor through Strait of Hormuz
Power cuts in France leave thousands sweltering amid scorching heatwave
Libya's eastern government bans entry of nationals from four African countries
New Lebanon-Israel talks begin in shadow of US-Iran deal
